{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T07:12:02Z","timestamp":1791616322234,"version":"4.3.4"},"reference-count":38,"publisher":"International Heart Journal (Japanese Heart Journal)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. Heart J."],"published-print":{"date-parts":[[2016]]},"DOI":"10.1536\/ihj.15-320","type":"journal-article","created":{"date-parts":[[2016,3,10]],"date-time":"2016-03-10T17:06:07Z","timestamp":1457629567000},"page":"204-210","source":"Crossref","is-referenced-by-count":17,"title":["Everolimus Attenuates Myocardial Hypertrophy and Improves Diastolic Function in Heart Transplant Recipients"],"prefix":"10.1536","volume":"57","author":[{"given":"Teruhiko","family":"Imamura","sequence":"first","affiliation":[{"name":"Department of Therapeutic Strategy for Heart Failure, Graduate School of Medicine, The University of Tokyo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichiro","family":"Kinugawa","sequence":"additional","affiliation":[{"name":"Department of Therapeutic Strategy for Heart Failure, Graduate School of Medicine, The University of Tokyo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Nitta","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osamu","family":"Kinoshita","sequence":"additional","affiliation":[{"name":"Department of Cardiac Surgery, Graduate School of Medicine, The University of Tokyo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kan","family":"Nawata","sequence":"additional","affiliation":[{"name":"Department of Cardiac Surgery, Graduate School of Medicine, The University of Tokyo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minoru","family":"Ono","sequence":"additional","affiliation":[{"name":"Department of Cardiac Surgery, Graduate School of Medicine, The University of Tokyo"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"437","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Messerli FH, Williams B, Ritz E. Essential hypertension. Lancet 2007; 370: 591-603. (Review)","DOI":"10.1016\/S0140-6736(07)61299-9"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 1990; 322: 1561-6.","DOI":"10.1056\/NEJM199005313222203"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Qin XJ, Li H, You J, <i>et al<\/i>. Left ventricle geometry remolding after heart transplantation: a two-dimensional ultrasound study. J Huazhong Univ Sci Technolog Med Sci 2013; 33: 892-6.","DOI":"10.1007\/s11596-013-1217-5"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Goodroe R, Bonnema DD, Lunsford S, <i>et al<\/i>. Severe left ventricular hypertrophy 1 year after transplant predicts mortality in cardiac transplant recipients. J Heart Lung Transplant 2007; 26: 145-51.","DOI":"10.1016\/j.healun.2006.11.003"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Aziz TM, Burgess MI, Haselton PS, Yonan NA, Hutchinson IV. Transforming growth factor beta and diastolic left ventricular dysfunction after heart transplantation: echocardiographic and histologic evidence. J Heart Lung Transplant 2003; 22: 663-73.","DOI":"10.1016\/S1053-2498(02)00657-5"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Hannan RD, Jenkins A, Jenkins AK, Brandenburger Y. Cardiac hypertrophy: a matter of translation. Clin Exp Pharmacol Physiol 2003; 30: 517-27. (Review)","DOI":"10.1046\/j.1440-1681.2003.03873.x"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Hedhli N, Pelat M, Depre C. Protein turnover in cardiac cell growth and survival. Cardiovasc Res 2005; 68: 186-96. (Review)","DOI":"10.1016\/j.cardiores.2005.06.025"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Siedlecki AM, Jin X, Muslin AJ. Uremic cardiac hypertrophy is reversed by rapamycin but not by lowering of blood pressure. Kidney Int 2009; 75: 800-8.","DOI":"10.1038\/ki.2008.690"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Boluyt MO, Li ZB, Loyd AM, Scalia AF, Cirrincione GM, Jackson RR. The mTOR\/p70S6K signal transduction pathway plays a role in cardiac hypertrophy and influences expression of myosin heavy chain genes in vivo. Cardiovasc Drugs Ther 2004; 18: 257-67.","DOI":"10.1023\/B:CARD.0000041245.61136.56"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Gao XM, Wong G, Wang B, <i>et al<\/i>. Inhibition of mTOR reduces chronic pressure-overload cardiac hypertrophy and fibrosis. J Hypertens 2006; 24: 1663-70.","DOI":"10.1097\/01.hjh.0000239304.01496.83"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. McMullen JR, Sherwood MC, Tarnavski O, <i>et al<\/i>. Inhibition of mTOR signaling with rapamycin regresses established cardiac hypertrophy induced by pressure overload. Circulation 2004; 109: 3050-5.","DOI":"10.1161\/01.CIR.0000130641.08705.45"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Shioi T, McMullen JR, Tarnavski O, <i>et al<\/i>. Rapamycin attenuates load-induced cardiac hypertrophy in mice. Circulation 2003; 107: 1664-70.","DOI":"10.1161\/01.CIR.0000057979.36322.88"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Klawitter J, Nashan B, Christians U. Everolimus and sirolimus in transplantation-related but different. Expert Opin Drug Saf 2015; 14: 1055-70.","DOI":"10.1517\/14740338.2015.1040388"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Raichlin E, Chandrasekaran K, Kremers WK, <i>et al<\/i>. Sirolimus as primary immunosuppressant reduces left ventricular mass and improves diastolic function of the cardiac allograft. Transplantation 2008; 86: 1395-400.","DOI":"10.1097\/TP.0b013e318189049a"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Peura JL, Zile MR, Feldman DS, <i>et al<\/i>. Effects of conversion from cyclosporine to tacrolimus on left ventricular structure in cardiac allograft recipients. J Heart Lung Transplant 2005; 24: 1969-72.","DOI":"10.1016\/j.healun.2005.02.011"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Imamura T, Kinugawa K, Ono M, <i>et al<\/i>. Everolimus-incorporated immunosuppressant strategy improves renal dysfunction while maintaining low rejection rates after heart transplantation in Japanese patients. Int Heart J 2013; 54: 222-7.","DOI":"10.1536\/ihj.54.222"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Imamura T, Kinugawa K, Doi K, <i>et al<\/i>. Plasma neutrophil gelatinase-associated lipocalin and worsening renal function during everolimus therapy after heart transplantation. Int Heart J 2015; 56: 73-9.","DOI":"10.1536\/ihj.14-179"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Gullestad L, Iversen M, Mortensen SA, <i>et al<\/i>. Everolimus with reduced calcineurin inhibitor in thoracic transplant recipients with renal dysfunction: a multicenter, randomized trial. Transplantation 2010; 89: 864-72.","DOI":"10.1097\/TP.0b013e3181cbac2d"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Stypmann J, Engelen MA, Eckernkemper S, <i>et al<\/i>. Calcineurin inhibitor-free immunosuppression using everolimus (Certican) after heart transplantation: 2 years\u2019 follow-up from the University Hospital Munster. Transplant Proc 2011; 43: 1847-52.","DOI":"10.1016\/j.transproceed.2010.12.062"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Budde K, Becker T, Arns W, <i>et al<\/i>. Everolimus-based, calcineurin-inhibitor-free regimen in recipients of de-novo kidney transplants: an open-label, randomised, controlled trial. Lancet 2011; 377: 837-47.","DOI":"10.1016\/S0140-6736(10)62318-5"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Eisen HJ, Tuzcu EM, Dorent R, <i>et al<\/i>. Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients. N Engl J Med 2003; 349: 847-58.","DOI":"10.1056\/NEJMoa022171"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Mancini D, Pinney S, Burkhoff D, <i>et al<\/i>. Use of rapamycin slows progression of cardiac transplantation vasculopathy. Circulation 2003; 108: 48-53.","DOI":"10.1161\/01.CIR.0000070421.38604.2B"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Ishida J, Kinugawa K, Shiga T, <i>et al<\/i>. Rapidly progressive cardiac allograft vasculopathy in early onset regressed with everolimus treatment in an adult cardiac recipient. Int Heart J 2012; 53: 388-90.","DOI":"10.1536\/ihj.53.388"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Imamura T, Kinugawa K, Mohri D, <i>et al<\/i>. A case of pancreatic cancer after heart transplantation. Int Heart J 2012; 53: 205-7.","DOI":"10.1536\/ihj.53.205"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Huang S, Houghton PJ. Targeting mTOR signaling for cancer therapy. Curr Opin Pharmacol 2003; 3: 371-7. (Review)","DOI":"10.1016\/S1471-4892(03)00071-7"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Imamura T, Kinugawa K, Hatano M, <i>et al<\/i>. Preoperative beta-blocker treatment is a key for deciding left ventricular assist device implantation strategy as a bridge to recovery. J Artif Organs 2014; 17: 23-32.","DOI":"10.1007\/s10047-013-0748-7"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Devereux RB, Reichek N. Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation 1997; 55: 613-8.","DOI":"10.1161\/01.CIR.55.4.613"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Lang RM, Bierig M, Devereux RB, <i>et al<\/i>. Recommendations for chamber quantification: a report from the American Society of Echocardiography\u2019s Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005; 18: 1440-63.","DOI":"10.1016\/j.echo.2005.10.005"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Opie LH, Haus M, Commerford PJ, Levetan B, Moore K, Brink J. Antihypertensive effects of angiotensin converting enzyme inhibition by lisinopril in post-transplant patients. Am J Hypertens 2002; 15: 911-6.","DOI":"10.1016\/S0895-7061(02)02992-8"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Wolf G, Thaiss F, Stahl RA. Cyclosporine stimulates expression of transforming growth factor-beta in renal cells. Possible mechanism of cyclosporines antiproliferative effects. Transplantation 1995; 60: 237-41.","DOI":"10.1097\/00007890-199508000-00005"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Imamura T, Kinugawa K, Shiga T, <i>et al<\/i>. An elevated ratio of early to late diastolic filling velocity recovers after heart transplantation in a time-dependent manner. J Cardiol 2012; 60: 295-300.","DOI":"10.1016\/j.jjcc.2012.05.011"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Stallone G, Infante B, Schena A, <i>et al<\/i>. Rapamycin for treatment of chronic allograft nephropathy in renal transplant patients. J Am Soc Nephrol 2005; 16: 3755-62.","DOI":"10.1681\/ASN.2005060635"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Kushwaha SS, Raichlin E, Sheinin Y, <i>et al<\/i>. Sirolimus affects cardiomyocytes to reduce left ventricular mass in heart transplant recipients. Eur Heart J 2008; 29: 2742-50.","DOI":"10.1093\/eurheartj\/ehn407"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Paoletti E, Marsano L, Bellino D, Cassottana P, Cannella G. Effect of everolimus on left ventricular hypertrophy of de novo kidney transplant recipients: a 1 year, randomized, controlled trial. Transplantation 2012; 93: 503-8.","DOI":"10.1097\/TP.0b013e318242be28"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Murbraech K, Massey R, Undset LH, Midtvedt K, Holdaas H, Aakhus S. Cardiac response to early conversion from calcineurin inhibitor to everolimus in renal transplant recipients--a three-yr serial echocardiographic substudy of the randomized controlled CENTRAL trial. Clin Transplant 2015; 29: 678-84.","DOI":"10.1111\/ctr.12565"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Farr MJ, Lang CC, Lamanca JJ, <i>et al<\/i>. Cardiopulmonary exercise variables in diastolic versus systolic heart failure. Am J Cardiol 2008; 102: 203-6.","DOI":"10.1016\/j.amjcard.2008.03.041"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Imamura T, Kinugawa K, Fujino T, <i>et al<\/i>. Recipients with shorter cardiopulmonary bypass time achieve improvement of parasympathetic reinnervation within 6 months after heart transplantation. Int Heart J 2014; 55: 440-4.","DOI":"10.1536\/ihj.14-111"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Imamura T, Kinugawa K, Okada I, <i>et al<\/i>. Parasympathetic reinnervation accompanied by improved post-exercise heart rate recovery and quality of life in heart transplant recipients. Int Heart J 2015; 56: 180-5.","DOI":"10.1536\/ihj.14-292"}],"container-title":["International Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/57\/2\/57_15-320\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T04:06:05Z","timestamp":1498277165000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/57\/2\/57_15-320\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1536\/ihj.15-320","relation":{},"ISSN":["1349-2365","1349-3299"],"issn-type":[{"value":"1349-2365","type":"print"},{"value":"1349-3299","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016]]}}}